Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial Chi, G., Gibson, C. M., Hernandez, A. F., Hull, R. D., Cohen, A. T., Harrington, R. A., Alkhalfan, F., Kalayci, A., Kerneis, M., Nafee, T., Goldhaber, S. Z., APEX Investigators OXFORD UNIV PRESS. 2018: 868

View details for Web of Science ID 000459824002741